+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate



Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate



BMJ 312(7045): 1512-1515



Objective: To examine the effectiveness in treating impotence of topically applied cream containing three vasodilators-aminophylline, isosorbide dinitrate, and co-dergocrine mesylate which act by different mechanisms. Design: Randomised double blinded placebo controlled crossover trial over two weeks. Subjects: 36 men with erectile dysfunction randomly allocated to two equal groups. Interventions: Active cream containing aminophylline 3%, isosorbide dinitrate 0.25%, and co-dergocrine mesylate 0.05% for one week and placebo for another. Main outcome measures: Patients' reported experience of penile responses and side effects of treatment in questionnaires. Penile tumescence and arterial flow in the laboratory. Results: 21 patients reported full erection and satisfactory intercourse with the active cream. Three men reported full erection and satisfactory intercourse with either cream. The active cream was more effective in psychogenic than organic impotence (eight out of nine men with psychogenic impotence achieved a full erection v four out of eight with neurogenic impotence and two out of seven with arterial insufficiency). No major side effects were reported. In the laboratory the active cream increased penile arterial flow (0.19 (SD 0.08) m/s v 0.02 (0.15) m/s with placebo) and induced tumescence in 24 patients. Conclusions: Topical treatment with a cream containing three different vasodilators might be considered before intracavernous injection of vasoactive agents, particularly in psychogenic impotence.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009654547

Download citation: RISBibTeXText

PMID: 8646143


Related references

Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women. International Journal of Pharmaceutical Compounding 6(4): 255-256, 2002

Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial. European Journal of Surgery 167(5): 382-385, 2001

Neurohumoral effects of ramipril in angina pectoris: A double-blind, placebo-controlled trial against isosorbide dinitrate and the combination of ramipril plus isosorbide dinitrate. Current Therapeutic Research 55(11): 1310-1322, 1994

Efficacy For Erectile Function And Lower Urinary Tract Symptoms Of Mirodenafil 50 Mg Once Daily In Patients With Erectile Dysfunction A Multicenter, Randomised, Double-Blind, Placebo-Controlled Trial. The Journal of Urology 187(4): e600-e601, 2012

Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris. International Journal of Cardiology 7(2): 149-156, 1985

Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial. Current Medical Research and Opinion 11(8): 491-500, 1989

A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. International Journal of Impotence Research 11(2): 91-97, 1999

Effects of a Topical Saffron (Crocus sativus L) Gel on Erectile Dysfunction in Diabetics: A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial. Journal of Evidence-Based Complementary and Alternative Medicine 20(4): 283-286, 2015

Topical treatment of atopic dermatitis with Hypericum cream. A randomised, placebo-controlled, double-blind half-side comparison study. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete 54(3): 248-253, 2003

Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial. Bjog 114(4): 437-447, 2007

UK-92,480, A new oral therapy for erectile dysfunction, a double-blind, placebo controlled trial with treatment taken as required. Journal of Urology 155(5 Suppl. ): 495A, 1996

A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction. Urology 57(2): 301-305, 2001

Fusidic acid cream in the treatment of impetigo in general practice: Double blind randomised placebo controlled trial. BMJ 324(7331): 203-206, 26 January, 2002

Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial. Journal of Andrology 23(6): 763-771, 2002

Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trial. Journal of Wound Care 27(8): 495-502, 2018